{{Rsnum
|rsid=2295633
|Gene=FAAH
|Chromosome=1
|position=46408711
|Orientation=minus
|GMAF=0.3535
|Gene_s=FAAH
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 42.5 | 13.3
| HCB | 75.2 | 21.2 | 3.6
| JPT | 66.4 | 31.9 | 1.8
| YRI | 15.0 | 48.3 | 36.7
| ASW | 15.8 | 63.2 | 21.1
| CHB | 75.2 | 21.2 | 3.6
| CHD | 70.6 | 26.6 | 2.8
| GIH | 31.7 | 53.5 | 14.9
| LWK | 22.7 | 43.6 | 33.6
| MEX | 44.8 | 48.3 | 6.9
| MKK | 25.6 | 53.2 | 21.2
| TSI | 45.1 | 40.2 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22473870
|Title=Contribution of genetic variants to pain susceptibility in Parkinson disease
}}

{{PMID Auto
|PMID=22832737
|Title=Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury
|OA=1
}}

{{PMID Auto
|PMID=17991615
|Title=Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing.
}}

{{PMID Auto
|PMID=19890266
|Title=More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.
|OA=1
}}

{{PMID Auto
|PMID=20054193
|Title=Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population.
}}

{{PMID Auto
|PMID=21423693
|Title=Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}